Please visit answersincme.com/ACJ860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in oncology discusses BRCA testing in patients with early-stage breast cancer. This activity also features a patient who shares her experience about genomic testing when being treated for early breast cancer. Upon completion of this activity, participants should be better able to: Recognize the growing importance of comprehensive genomic testing, including BRCA1/2 mutational testing, in patients with early-stage breast cancer; Outline practical, patient-centered strategies to facilitate BRCA1/2 mutational testing in patients with early-stage breast cancer; and Evaluate the clinical significance of the latest trial data for neoadjuvant and adjuvant treatment of patients with BRCA-mutated, early-stage breast cancer.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related